middle.news
Race Oncology Advances RC220 Trial with Korean IND Approval
9:07am on Wednesday 24th of September, 2025 AEST
•
Healthcare
Read Story
Race Oncology Advances RC220 Trial with Korean IND Approval
9:07am on Wednesday 24th of September, 2025 AEST
Key Points
Korean MFDS grants IND approval for RC220 Phase 1 trial
Approval follows rigorous review of chemistry, manufacturing, and clinical data
Patient recruitment to begin at three sites with a fourth pending ethics approval
Regulatory clearance complements prior approvals in Australia and Hong Kong
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RAC
OPEN ARTICLE